Format

Send to

Choose Destination
See comment in PubMed Commons below
J Pediatr. 2004 Aug;145(2 Suppl):S33-5.

The emerging role of therapeutic botulinum toxin in the treatment of cerebral palsy.

Author information

1
Kennedy Krieger Institute and Department of Physical Medicine and Rehabilitation, Johns Hopkins School of Medicine, Baltimore, Maryland 21205, USA. pidcock@kennedyk-rieger.org

Abstract

Therapeutic injections of botulinum toxin have been used for the past decade to decrease muscle tone in children with cerebral palsy. Although this unique intervention has been shown to provide safe localized spasticity reduction, functional benefits have been more difficult to demonstrate. Appropriate selection of patients and clearly defined goals are key factors in the success of a treatment program. The therapeutic approach to treating children with cerebral palsy should include a variety of complementary interventions that address the effect of abnormal muscle tone on the abilities of these children as they grow and develop.

PMID:
15292885
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science
    Loading ...
    Support Center